Search Results - "SANTER, Peter"

Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III by Pechlaner, Raimund, MD, PhD, Tsimikas, Sotirios, MD, Yin, Xiaoke, PhD, Willeit, Peter, MD, PhD, Baig, Ferheen, MSc, Santer, Peter, MD, Oberhollenzer, Friedrich, MD, Egger, Georg, MD, Witztum, Joseph L., MD, Alexander, Veronica J., PhD, Willeit, Johann, MD, Kiechl, Stefan, MD, Mayr, Manuel, MD, PhD

“…Abstract Background Routine apolipoprotein (apo) measurements for cardiovascular disease (CVD) are restricted to apoA-I and apoB. Here, the authors measured an…”
Get full text

Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck Study by Stegemann, Christin, Pechlaner, Raimund, Willeit, Peter, Langley, Sarah R, Mangino, Massimo, Mayr, Ursula, Menni, Cristina, Moayyeri, Alireza, Santer, Peter, Rungger, Gregor, Spector, Tim D, Willeit, Johann, Kiechl, Stefan, Mayr, Manuel

“…BACKGROUND—The bulk of cardiovascular disease risk is not explained by traditional risk factors. Recent advances in mass spectrometry allow the identification…”
Get full text

On the Metabolism of Exogenous Ketones in Humans by Stubbs, Brianna J, Cox, Pete J, Evans, Rhys D, Santer, Peter, Miller, Jack J, Faull, Olivia K, Magor-Elliott, Snapper, Hiyama, Satoshi, Stirling, Matthew, Clarke, Kieran

“…Currently there is considerable interest in ketone metabolism owing to recently reported benefits of ketosis for human health. Traditionally, ketosis has been…”
Get full text

Oxidation-Specific Biomarkers, Prospective 15-Year Cardiovascular and Stroke Outcomes, and Net Reclassification of Cardiovascular Events by Tsimikas, Sotirios, MD, Willeit, Peter, MD, MPhil, Willeit, Johann, MD, Santer, Peter, MD, Mayr, Manuel, MD, PhD, Xu, Qingbo, PhD, Mayr, Agnes, MD, Witztum, Joseph L., MD, Kiechl, Stefan, MD

“…Objectives This study sought to assess the long-term predictive value and net reclassification for risk of cardiovascular disease (CVD) of biomarkers…”
Get full text

Association Between Intraoperative Arterial Hypotension and Postoperative Delirium After Noncardiac Surgery: A Retrospective Multicenter Cohort Study by Wachtendorf, Luca J., Azimaraghi, Omid, Santer, Peter, Linhardt, Felix C., Blank, Michael, Suleiman, Aiman, Ahn, Curie, Low, Ying H., Teja, Bijan, Kendale, Samir M., Schaefer, Maximilian S., Houle, Timothy T., Pollard, Richard J., Subramaniam, Balachundhar, Eikermann, Matthias, Wongtangman, Karuna

“…It is unclear whether intraoperative arterial hypotension is associated with postoperative delirium. We hypothesized that intraoperative hypotension within a…”
Get full text

Signature of circulating microRNAs in osteoarthritis by Beyer, Christian, Zampetaki, Anna, Lin, Neng-Yu, Kleyer, Arnd, Perricone, Carlo, Iagnocco, Annamaria, Distler, Alfiya, Langley, Sarah R, Gelse, Kolja, Sesselmann, Stefan, Lorenzini, Rolando, Niemeier, Andreas, Swoboda, Bernd, Distler, Jörg H W, Santer, Peter, Egger, Georg, Willeit, Johann, Mayr, Manuel, Schett, Georg, Kiechl, Stefan

“…Osteoarthritis is the most common form of arthritis and a major socioeconomic burden. Our study is the first to explore the association between serum microRNA…”
Get more information

Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease by Uderhardt, Stefan, Ackermann, Jochen A, Fillep, Tobias, Hammond, Victoria J, Willeit, Johann, Santer, Peter, Mayr, Manuel, Biburger, Markus, Miller, Meike, Zellner, Katie R, Stark, Konstantin, Zarbock, Alexander, Rossaint, Jan, Schubert, Irene, Mielenz, Dirk, Dietel, Barbara, Raaz-Schrauder, Dorette, Ay, Cihan, Gremmel, Thomas, Thaler, Johannes, Heim, Christian, Herrmann, Martin, Collins, Peter W, Schabbauer, Gernot, Mackman, Nigel, Voehringer, David, Nadler, Jerry L, Lee, James J, Massberg, Steffen, Rauh, Manfred, Kiechl, Stefan, Schett, Georg, O'Donnell, Valerie B, Krönke, Gerhard

“…Blood coagulation is essential for physiological hemostasis but simultaneously contributes to thrombotic disease. However, molecular and cellular events…”
Get full text

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease by KIECHL, Stefan, SCHETT, Georg, WENNING, Gregor, REDLICH, Kurt, OBERHOLLENZER, Martin, MAYR, Agnes, SANTER, Peter, SMOLEN, Josef, POEWE, Werner, WILLEIT, Johann

“…Osteoprotegerin is a novel member of the tumor necrosis factor receptor superfamily and a soluble decoy receptor of the receptor activator of nuclear…”
Get full text

Associations of Serum Dickkopf-1 and Sclerostin With Cardiovascular Events: Results From the Prospective Bruneck Study by Klingenschmid, Gerhard, Tschiderer, Lena, Himmler, Gottfried, Rungger, Gregorio, Brugger, Stefan, Santer, Peter, Willeit, Johann, Kiechl, Stefan, Willeit, Peter

“…Background Dickkopf-1 and sclerostin have been implicated in atherosclerosis and vascular calcification. We aimed to quantify the association of their serum…”
Get full text

Evaluation of early postoperative intravenous opioid rescue as a novel quality measure in patients who receive thoracic epidural analgesia: a retrospective cohort analysis and prospective performance improvement intervention by Levy, Nadav, Santer, Peter, Zucco, Liana, Nabel, Sarah, Korsunsky, Galina, Ramachandran, Satya Krishna

“…In this study, we explored the utility of intravenous opioid rescue analgesia in the post anesthesia care unit (PACU-OpResc) as a single marker of thoracic…”
Get full text

Study protocol for a randomised controlled trial evaluating the effects of the orexin receptor antagonist suvorexant on sleep architecture and delirium in the intensive care unit by Azimaraghi, Omid, Hammer, Maximilian, Santer, Peter, Platzbecker, Katharina, Althoff, Friederike C, Patrocinio, Maria, Grabitz, Stephanie D, Wongtangman, Karuna, Rumyantsev, Sandra, Xu, Xinling, Schaefer, Maximilian S, Fuller, Patrick M, Subramaniam, Balachundhar, Eikermann, Matthias

“…IntroductionInsomnia frequently occurs in patients admitted to an intensive care unit (ICU). Sleep-promoting agents may reduce rapid eye movement sleep and…”
Get full text

Effect of OSA on hypoxic and inflammatory markers during CPAP withdrawal: Further evidence from three randomized control trials by Turnbull, Chris D., Rossi, Valentina A., Santer, Peter, Schwarz, Esther I., Stradling, John R., Petousi, Nayia, Kohler, Malcolm

“…ABSTRACT Background and objective Obstructive sleep apnoea (OSA) is associated with cardiovascular disease. Intermittent hypoxia, endothelial dysfunction and…”
Get full text

Recent advances in understanding and managing postoperative respiratory problems [version 1; peer review: 2 approved] by Eikermann, Matthias, Santer, Peter, Ramachandran, Satya-Krishna, Pandit, Jaideep

“…Postoperative respiratory complications increase healthcare utilization (e.g. hospital length of stay, unplanned admission to intensive care or high-dependency…”
Get full text

Driving cessation and dementia: results of the prospective registry on dementia in Austria (PRODEM) by Seiler, Stephan, Schmidt, Helena, Lechner, Anita, Benke, Thomas, Sanin, Guenter, Ransmayr, Gerhard, Lehner, Riccarda, Dal-Bianco, Peter, Santer, Peter, Linortner, Patricia, Eggers, Christian, Haider, Bernhard, Uranues, Margarete, Marksteiner, Josef, Leblhuber, Friedrich, Kapeller, Peter, Bancher, Christian, Schmidt, Reinhold

“…To assess the influence of cognitive, functional and behavioral factors, co-morbidities as well as caregiver characteristics on driving cessation in dementia…”
Get full text

OXIDATION-SPECIFIC BIOMARKERS AND PROSPECTIVE 15-YEAR CARDIOVASCULAR AND STROKE OUTCOMES by Tsimikas, Sotirios, Willeit, Peter, Willeit, Johann, Santer, Peter, MD, Mayr, Manuel, Xu, Qingbo, Mayr, Agnes, Witztum, Joseph, Kiechl, Stefan

“…Results Over 15 years of follow-up from 1995-2010, 138 subjects reached the primary endpoint of incident CVD (ischemic stroke, myocardial infarction, new-onset…”
Get full text

Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a) by Willeit, Peter, MD, PhD, Kiechl, Stefan, MD, Kronenberg, Florian, MD, Witztum, Joseph L., MD, PhD, Santer, Peter, MD, Mayr, Manuel, MD, PhD, Xu, Qingbo, MD, PhD, Mayr, Agnes, MD, Willeit, Johann, MD, Tsimikas, Sotirios, MD

“…Abstract Background Recent studies showed that lipoprotein(a) [Lp(a)] is a causal risk factor for cardiovascular disease (CVD). However, whether Lp(a) modifies…”
Get full text

Unrecognized Obstructive Sleep Apnea in Patients Undergoing Surgery by Santer, Peter, Eikermann, Matthias

Get full text

High-dose midodrine is not effective for treatment of persistent hypotension in the intensive care unit by Santer, Peter, Eikermann, Matthias

Get full text

Tetrahydrobiopterin compounds modulate intracellular signaling and reactive oxygen species levels in an in vitro model of ischemia-reperfusion injury by Santer Peter, Ratschiller Thomas, Ashraf Muhammad Imtiaz, Werner Ernst R., Werner-Felmayer Gabriele, Maglione Manuel, Brandacher Gerald, Troppmair Jakob

“…Tetrahydrobiopterin (BH4) and 4-amino-tetrahydrobiopterin (ABH4) prevent acute rejection after solid organ transplantation. Moreover, BH4 also attenuates…”
Get full text

Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a): Prospective 15-Year Outcomes in the Bruneck Study by WILLEIT, Peter, KIECHL, Stefan, KRONENBERG, Florian, WITZTUM, Joseph L, SANTER, Peter, MAYR, Manuel, QINGBO XU, MAYR, Agnes, WILLEIT, Johann, TSIMIKAS, Sotirios

“…Recent studies showed that lipoprotein(a) [Lp(a)] is a causal risk factor for cardiovascular disease (CVD). However, whether Lp(a) modifies clinical risk…”
Get full text